RAG1/2 expression in IGH-switched follicular lymphoma associated with transformation to high-grade B-cell lymphoma.

Lonardi S; Cancila V; Morello G; Varano G; Balzarini P; Pellegrini V; Albertini E; Giampaolo S; Pietrini I; Thanasi H; Sindaco P; Piazza F; Manni S; Lorenzini D; Pruneri G; Dei Tos AP; Ponzoni M; Facchetti F; Pizzi M; Lorenzi L; Tripodo C; Casola S

doi:10.1038/s41375-026-02896-4

← 뒤로

RAG1/2 expression in IGH-switched follicular lymphoma associated with transformation to high-grade B-cell lymphoma.

0/5 보강

Leukemia 📖 저널 OA 68.9% 2025~2026 2026

Lonardi S, Cancila V, Morello G, Varano G, Balzarini P, Pellegrini V

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Lonardi S, Cancila V, et al. (2026). RAG1/2 expression in IGH-switched follicular lymphoma associated with transformation to high-grade B-cell lymphoma.. Leukemia. https://doi.org/10.1038/s41375-026-02896-4

MLA Lonardi S, et al.. "RAG1/2 expression in IGH-switched follicular lymphoma associated with transformation to high-grade B-cell lymphoma.." Leukemia, 2026.

PMID 41792441 ↗

DOI 10.1038/s41375-026-02896-4

같은 제1저자의 인용 많은 논문 (2)

Pharmacokinetics and safety of subcutaneous nivolumab: results from the phase I/II CheckMate 8KX study.
Journal for immunotherapy of cancer 2025
Long-term survival in patients with pancreatic cancer treated with second-line liposomal irinotecan plus 5-fluorouracil/leucovorin: observations from Korea, Italy, and Germany.
ESMO gastrointestinal oncology 2025